Cumberland Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.09-$7.25 |
Market Cap | $33M |
Shares Short | 34,075 |
Financials
See moreRevenue (12 Mos) | $41.2M |
Revenue Growth (YoY) | -8.7% |
Gross Profit (12 Mos) | $34.8M |
Diluted EPS | -$0.24 |
News
See moreYahoo Finance • 23 days ago
Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline
Yahoo Finance • 3 months ago
Sitryx appoints Adam Mostafa as Chief Financial Officer
Yahoo Finance • 4 months ago
Cumberland Pharmaceuticals Leads The Charge With 2 Other Prominent Penny Stocks
Yahoo Finance • 4 months ago
Friday Insider Trading: Top Buys and Sells from Friday, July 13, 2025
About
CEO | Mr. A. J. Kazimi MBA |
CFO | Mr. John Michael Hamm C.M.A. |
Address | 1600 West End Avenue, Nashville, TN, United States, 37203 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 91 |
